Symptoms of Gestational Diabetes
Gestational diabetes mellitus (GDM) is typically asymptomatic and does not present with noticeable symptoms in most pregnant women, which is precisely why universal screening between 24-28 weeks of gestation is mandatory. 1, 2, 3
Clinical Presentation
Most Common Scenario: No Symptoms
The vast majority of women with GDM experience no symptoms whatsoever. GDM is defined as glucose intolerance with onset or first recognition during pregnancy 1, and unlike overt diabetes, the degree of hyperglycemia is usually insufficient to cause classic diabetic symptoms. This asymptomatic nature is why screening protocols exist—waiting for symptoms would miss the vast majority of cases and their associated complications.
When Symptoms Do Occur
In rare cases where glucose levels are severely elevated (approaching overt diabetes thresholds), women may experience:
- Polyuria (excessive urination)
- Polydipsia (excessive thirst)
- Polyphagia (excessive hunger)
- Glycosuria (glucose in urine, though this alone is not diagnostic) 1, 2
However, these symptoms indicate glucose levels ≥200 mg/dL, which would classify as overt diabetes in pregnancy rather than typical GDM 2, 4.
Critical Clinical Distinction
If a pregnant woman presents with classic hyperglycemic symptoms (polyuria, polydipsia, polyphagia) and random plasma glucose ≥200 mg/dL, or fasting glucose ≥126 mg/dL, or HbA1c ≥6.5%, she has overt diabetes—not gestational diabetes—and requires immediate intensive management 2, 4.
Why Screening Matters More Than Symptoms
The absence of symptoms does not mean absence of risk. GDM without symptoms still significantly increases risks for:
- Maternal complications: Preeclampsia, hypertensive disorders, cesarean delivery 3, 5
- Fetal complications: Macrosomia (large baby >4,000-4,500g), shoulder dystocia, birth injury 3, 5
- Neonatal complications: Hypoglycemia, respiratory distress 6, 5
- Long-term risks: 15-60% of women develop type 2 diabetes within 5-15 years 1, 3
Screening Approach (Not Symptom-Based)
High-Risk Women Requiring Early Screening
Screen at first prenatal visit if any of these risk factors present 1, 2:
- Marked obesity (BMI ≥25 kg/m², or ≥23 kg/m² for Asian Americans)
- Personal history of GDM
- Strong family history of diabetes
- Age >35 years
- Previous baby >4,500g
- Glycosuria detected on urinalysis
- Polycystic ovary syndrome
- Ethnic groups at high risk (Hispanic, South Asian, Southeast Asian, Arab, Native American)
Universal Screening
All pregnant women without previously diagnosed diabetes must undergo 75g oral glucose tolerance test (OGTT) at 24-28 weeks of gestation 2, 4, 7.
Common Pitfall to Avoid
Do not wait for symptoms to develop before testing for GDM. The entire rationale for universal screening programs is that GDM is asymptomatic. By the time symptoms appear, glucose levels are typically in the overt diabetes range, indicating more severe disease with higher complication rates 6. Women diagnosed with GDM in early pregnancy (before 24 weeks) represent a particularly high-risk subgroup with increased rates of hypertension, insulin requirement, neonatal hypoglycemia, and perinatal mortality 6.
The key message: GDM is a laboratory diagnosis made through screening, not a clinical diagnosis made through symptoms.